Skip to main content
Equibles
ITGR logo

ITGR · Integer Holdings Corp

Track ITGR — free

Use ITGR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ITGR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$126.65 -0.11 (-0.08%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$4.31B
Shares
34.00M
Volume · Nov 6 209.64K Avg daily vol (3M) 842.53K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$126.75 Open$126.73 Day$126.59–126.81 52W close$66.64–126.75 Avg vol 30d867K Short int3.2M · 9.6% of shares · 3.7d Short vol67% Last earningsOct 29, 2026 DataJan 2020–Nov 2026 Filing10-Q · Oct 29

Up next

Next earnings call
Jan 28, 2027 Est · unconfirmed · in 12 wks
Q1 2026 earnings call transcript
call held Apr 30, 2026
Play latest call

Latest documents

2026
Oct 29
Quarterly report 10-Q FY2026 Q3, ended Oct 2
Quarterly report for FY2026 Q3

Integer Holdings Corporation’s August 2, 2026 merger agreement provides $127 in cash per common share, with closing anticipated by the end of 2026. Third-quarter income from continuing operations fell to $15.0 million from $39.7 million.

Revenue $449.66M ▼ 3.9% Net income $14.98M ▼ 62.3% Diluted EPS $0.43 ▼ 61.3%
Read from the MD&A section
Oct 29
Current report 8-K
Sales fall 3.9% as KKR affiliate transaction remains pending

Integer reported third-quarter sales down 3.9% to $450 million and adjusted EBITDA down 17% to $88 million. Stockholders approved the KKR affiliate acquisition on October 21, 2026; closing is anticipated by the end of 2026, subject to remaining conditions and regulatory approvals.

Financial results
3 source passages
Sales decreased 3.9% to $450 million. Organic sales decreased 2.2%. Adjusted EBITDA totaled $88 million, a decrease of $18 million or 17%. On October 21, 2026, Integer's stockholders approved the adoption of the Merger Agreement. The Transaction is anticipated to close by the end of 2026, subject to the satisfaction or waiver of the remaining customary closing conditions specified in the Merger Agreement, including receipt of required regulatory approvals. Open the document at this passage
Oct 21
Current report 8-K
Shareholder vote results, Regulation FD disclosure

Integer Holdings Corporation stockholders approved the merger agreement with Armstrong Parent, Inc. and Armstrong Bidco, Inc.; the transaction is expected to close by the end of 2026, subject to customary closing conditions and regulatory approvals.

Oct 14
Current report 8-K
Other events

Integer Holdings Corporation voluntarily supplemented proxy disclosures amid three stockholder complaints alleging omitted or misleading merger information; a vote on the merger is scheduled for October 21, 2026, at 9 a.m. Central Time.

Oct 2
Current report 8-K
Other events

Integer Holdings Corporation’s 2.125% Convertible Senior Notes due 2028 became holder-convertible from October 1, 2026 through December 31, 2026, at 11.4681 shares per $1,000 principal amount, equivalent to approximately $87.20 per share.

All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.83B
Trailing 12 months
Net income (TTM)
$103.70M
Trailing 12 months
Revenue growth YoY
-3.9%
Year over year
Operating margin
8.2%
Trailing 12 months
P / E (TTM)
42.2
Trailing earnings · reciprocal yield 2.4%
FCF yield
1.9%
TTM · current market cap
Return on invested capital
4.9%
Trailing 12 months
Net cash
−$1.21B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-2.8%
Year over year · fewer shares
Price change (1Y)
+84.6%
Trailing year
Short interest
9.6%
Latest settlement · 3.7 days to cover
View all 122 metrics

Quarterly results

Revenue Net income Net loss
▲18.3% $449.50M $32.70M '24 Q4* ▲7.3% $437.39M −$22.49M '25 Q1 ▲11.4% $476.49M $37.01M '25 Q2 ▲8.4% $467.69M $39.68M '25 Q3 ▲5% $472.06M $48.61M '25 Q4* ▲0.5% $439.58M $16.51M '26 Q1 ▼2.6% $464.11M $23.61M '26 Q2 LATEST ▼3.9% $449.66M $14.98M '26 Q3

* Q4 derived as the full year minus Q1 to Q3.

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Bearish Fundamentals Fair Quant / Vol Very Low
Market backdrop VIX 28.2 · fear Equity put/call 0.89
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +25%
above
Price vs 50-day avg +0%
above
RSI (14) 66
neutral
MACD trend Negative
52-week position 100%
near high
Momentum
relative strength
Very Strong
1-month return 0%
trailing
6-month return +44%
trailing
YTD return +62%
this year
Relative strength +45%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $126 › 200d $102 — 50d above 200d
Institutional flow Distributing
145 of 336 funds reported for Sep 30 · net -1.3M sh shares · +24 new
Insider flow Distributing
Net -$5.2M over 90 days · 100% sells
Short interest Rising
9.56% of shares out · ▲ +3.7% MoM · 3.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
336 holders — mid 3-yr range
Squeeze score 69
elevated · 0–100
Fundamentals
Fair
Revenue growth +8%
Y/Y
Gross margin 27%
expanding
EPS growth −14%
Y/Y
Free cash flow $105.1M
Valuation P/E 42.3
rich
Buyback $100.0M
remaining
Balance sheet $1.2B
net debt
Quant / Vol
risk profile
Very Low
Volatility 32%
annualized · 1-yr
Max drawdown −7%
past year
ATR 0.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 5 of last 7
Latest guidance · from the Earnings Call filed Apr 30, 2026
full year 2026
Adjusted EBITDA Non-GAAP Lowered $375M – $399M
Feb 19, 2026 $391M – $415M changed to Apr 30, 2026 $375M – $399M
Adjusted operating income Non-GAAP Lowered $285M – $305M
Feb 19, 2026 $304M – $324M changed to Apr 30, 2026 $285M – $305M
Adjusted net income Non-GAAP Lowered $200M – $220M
Feb 19, 2026 $216M – $232M changed to Apr 30, 2026 $200M – $220M
Adjusted earnings per share Non-GAAP Lowered $5.83 – $6.40
Feb 19, 2026 $6.29 – $6.78 changed to Apr 30, 2026 $5.83 – $6.40
Cash flow from operations $185M – $205M
Capital expenditures Maintained $95M – $105M
Feb 19, 2026 $95M – $105M changed to Apr 30, 2026 $95M – $105M
Free cash flow Lowered $85M – $105M
Feb 19, 2026 $100M – $120M changed to Apr 30, 2026 $85M – $105M
Full-year tax rate 16% – 18%
2026 year-end
Net total debt $1.19B – $1.21B
Previous outlook earlier release · from the 8-K filed Feb 19, 2026

Still-open targets the latest release did not restate under the same label.

Operating income · 2026 $304M – $324M
Diluted earnings per share · 2026 $6.29 – $6.78
Adjusted effective tax rate · 2026 16% – 18%
Guided vs delivered · last 7 settled
Sales 2024 Outlook
guided $1.74B – $1.77B
$1.72B Miss −2.0%
Diluted earnings per share 2024 Outlook
guided $3.30 – $3.71
$3.36 In line
Diluted earnings per share 2023
guided $2.45 – $2.65
$2.69 Beat +5.5%
Sales 2022 Outlook
guided $1.35B – $1.38B
$1.33B Miss −2.5%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 2 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+25% Bullish
Price vs 50-day avg
+0% Bullish
RSI (14)
66 Neutral
MACD trend
Negative Bearish
52-week position
100% Bullish
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross) No cross
50d $126 › 200d $102 — 50d above 200d
Institutional flow Distributing
145 of 336 funds reported for Sep 30 · net -1.3M sh shares · +24 new
Insider flow Distributing
Net -$5.2M over 90 days · 100% sells
Short interest Rising
9.56% of shares out · ▲ +3.7% MoM · 3.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
336 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $67 Now $127 · 100% Range high $127
vs 200-day avg +25% vs 50-day avg +0%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted net income non-GAAP 142.14M nine months ended October 2, 2026 —
Adjusted net income (Non-GAAP) non-GAAP $198.67M Nine Months Ended October 2, 2026 —
Adjusted weighted average shares (non-GAAP) non-GAAP 34.3M Nine Months Ended October 2, 2026 —
Leverage ratio non-GAAP 3.3 as of October 2, 2026 —
Non-GAAP net total debt non-GAAP 1.22B as of October 2, 2026 —
Organic Change (Total Sales, QTD) non-GAAP -2.2% three months ended October 2, 2026 —
Organic sales decreased non-GAAP 2.2% third quarter 2026 —
Total Sales non-GAAP -0.8% YTD Change (9M 2026 vs. 9M 2025) —
Gross margin 24.3% the three months ended July 3, 2026 filing —
Adjusted diluted EPS (Non-GAAP) non-GAAP $2.8 the six months ended July 3, 2026 —
Non-GAAP Organic Change (Total Sales, QTD) non-GAAP -1.5% 2Q 2026 vs. 2Q 2025 —
Total debt 1.24B July 3, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ITGR
Integer Holdings Corp
this stock
$4.31B +61.6% +8.0% 42.3 9.6%
ABT
Abbott Laboratories
 $196.75B -9.3% +5.7% 42.4 1.0%
MDT
Medtronic plc
 $134.10B +9.1% +8.4% 25.8 10.9%
SYK
Stryker Corp
 $127.55B -4.7% +11.2% 35.7 1.5%
BSX
Boston Scientific Corp
 $64.70B -53.2% +12.5% 18.9 2.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
343
% held
118.7%
Reported
145 of 336
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
329
View
Short & Settlement
Short Interest Rising
Shares short
3.2M
Days to cover
3.7d
Change
+114.5K sh
View
Short Volume
Short vol %
67%
As of
Nov 5, 2026
Short Total
View
Fails to Deliver
FTD shares
2
Value
$253
As of
Sep 18, 2026
View
Off-Exchange
Off-exchange %
56.4%
Week of
Sep 28, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$5.2M
Buyers / Sellers
0 / 2
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$1.9B
Net income (FY)
$102.8M
EPS diluted
$2.89
View
Buybacks
Authorized · 2 programs
$250.0M
Remaining
$100.0M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Oct 29, 2026
This year
34

Integer Holdings Corporation’s August 2, 2026 merger agreement provides $127 in cash per common share, with closing anticipated by the end of 2026. Third-quarter income from continuing operations fell to $15.0 million from $39.7 million.

View
Proposed Sales
Value
$593.6K
Shares
4.7K
Filed
Sep 15, 2026
View
Earnings & Events
Webcasts
Last webcast
Oct 29, 2026
View
Investor Relations
Latest news
Integer Holdings Corporation Repo…
Published
Oct 29, 2026
View

Performance

5D 20D 120D MTD YTD
ITGR +0.2% +0.1% +43.8% +0.1% +61.6%
SPY -4.7% -5.3% -0.8% -3.0% +7.5%
vs SPY +4.9% +5.4% +44.6% +3.1% +54.1%

Capital returns

Buyback programs · 2 active · as of Oct 2, 2026
Authorized (total)
$250.00M
Spent (derived)
$150.00M
Remaining
$100.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1114483 CUSIP 45826H109 13F (30d) 165 filings 129 filers Visit website Investor relations